Pharmaceuticals

Global Aduhelm Market 2026–2030: Forecast Insights for Business Planning

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the aduhelm market from 2026–2035 with trusted insights from The Business Research Company

How much is the Aduhelm Market valued at in 2026, and what valuation is forecast for 2030?

The expansion observed over the historical timeframe was primarily driven by an increasingly older worldwide populace, the absence of effective Alzheimer’s cures, significant progress in amyloid research, a rise in the prevalence of dementia, and a greater number of neurological clinical trials.

The anticipated growth during the forecast period is influenced by the expanding pool of Alzheimer’s patients, an increasing demand for early intervention treatments, the broadening adoption of biomarker-based diagnostics, greater healthcare spending on neurology, and the advancement in developing next-generation monoclonal antibodies.

Key trends observed for the forecast period include a heightened focus on therapies that modify Alzheimer’s disease, the growing utilization of monoclonal antibodies in neurological care, increased financial commitment to neurodegenerative research, a significant emphasis on early Alzheimer’s detection, and the expanding range of amyloid-targeting treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19857&type=smp

What Drivers Are Influencing The Growth Of The Aduhelm Market?

The anticipated expansion of the Aduhelm market going forward is linked to the rising incidence of Alzheimer’s disease. This condition, Alzheimer’s disease, is a progressive neurodegenerative disorder marked by the deterioration of cognitive abilities including memory, reasoning, and behavioral control. The uptick in Alzheimer’s disease cases stems from a confluence of factors, primarily demographic shifts, medical advancements, and societal changes. Aduhelm (aducanumab-avwa) serves as a treatment for Alzheimer’s disease, operating by targeting and diminishing amyloid-beta plaques in the brain, elements thought to fuel the disease’s advancement. To illustrate, data from May 2024, released by the Alzheimer Society, a UK-based organization aiding individuals with dementia, indicates that approximately 982,000 people in the UK currently live with dementia, with this number anticipated to climb to 1.4 million by 2040. Consequently, the growing prevalence of Alzheimer’s disease is fueling the expansion of the Aduhelm market.

How Is The Aduhelm Market Organized Into Various Segments?

The aduhelm market covered in this report is segmented –

1) By Indication: Mild Cognitive Impairment, Mild Dementia

2) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

3) By End User: Adult, Geriatric

Which Trends Are Expected To Influence The Aduhelm Market In The Upcoming Years?

Leading companies in the Aduhelm market are concentrating on developing innovative products, such as self-injectable monoclonal antibody formulations, to improve patient convenience and adherence. A self-injectable formulation enables patients to administer maintenance doses themselves using a prefilled pen or syringe, thereby reducing their reliance on hospital infusions. For instance, in 2025, Eisai and Biogen, a US- and Japan-based biopharmaceutical collaboration focused on neurological therapies and antibody-based medicines, introduced Leqembi Iqik (lecanemab self-injectable pen). Its main attributes include a patient-friendly prefilled pen for at-home use, a dosing regimen specifically for maintenance therapy, safety and tolerability data comparable to the IV version, and a design aimed at minimizing needle anxiety for patients.

Who Are The Primary Competitors In The Global Aduhelm Market?

Major companies operating in the aduhelm market are Biogen Inc., Eisai Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/aduhelm-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Aduhelm Market?

North America was the largest region in the aduhelm market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aduhelm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Aduhelm Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19857&type=smp

Browse Through More Reports Similar to the Global Aduhelm Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Adtech Market Report 2026

https://www.thebusinessresearchcompany.com/report/adtech-global-market-report

Print Advertising Distribution Market Report 2026

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795